FDA
approval
· 2019-02-07
FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Original Application (Accord Healthcare Inc.)
Summary
The FDA approved Accord Healthcare's olmesartan medoxomil and hydrochlorothiazide as an original generic combination therapy for hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE)